Location: Home
  • search
  • go
  • Relate News
  • 7/26/2025Ambroxol Hydrochloride Drops Reclassified as OTC Drug in China
  • 7/26/2025China's Basic Medical Insurance Fund Reports Surplus in H1/2025
  • 7/26/2025Recent Official and Executive Moves
  • 7/26/2025China's Sciwind in Licensing Talks to Bring Weight-Loss Drug to U.S. M...
  • 7/26/2025China Leads Global Expansion in Clinical Trial Volume in Q2 2025: Glob...
  • 7/25/2025China Launches Nationwide Pilot Program for Smart Medical Insurance Ov...
  • 7/25/2025Everest Secures $200M in Share Placement while Epirium Bio Prepares $5...
  • 7/25/2025AusperBio Advances AHB‑137 to Phase 3 After Green Light from China NM...
  • 7/25/2025Eisai's Lenvatinib Secures NMPA Approval in China
  • 7/25/2025Yangtze River Pharma's Tunodafil Wins NMPA Nod
  • 7/25/2025Newish Secures Series B1 Investment to Propel Nucleic Acid Cancer Vac...
  • 7/24/2025Zonsen PepLib Biotech Closes ~CNY 100M Series B Round
  • 7/24/2025Cascade Pharma's CS0159 Wins FDA Breakthrough For PBC
  • 7/24/2025Kelun-Biotech Initiates Phase I Trial of SKB107
  • 7/24/2025Pfizer Finalizes 3SBio Deal, Prepares Global Phase 3 Launch for BsAb S...
  • 7/24/2025Roche Sees Strong China Pharma Growth in H12025
  • 7/23/2025Kelun‑Biotech Launches Phase I Trial of SKB107 in China to Tackle Bon...
  • 7/23/2025Qilu Initiates Global Phase III Trial of QLS31905 for Pancreatic Cance...
  • 7/23/2025DualityBio's DB‑1310 Earns FDA Fast‑Track for EGFR‑Mutated Lung Can...
  • 7/23/2025SAMR Orders Simcere to Reverse Unnotified Merger Over Competition, Pri...
  • 7/23/2025China-Singapore Nanovaccine Prevents Cancer Recurrence in Animals
  • 7/23/2025Accelerating US Oncology Drug Development Using Chinese First-in-Human...
  • 7/22/2025PharmaDJ's China Biopharma Tracker – June 2025 (PharmaDJ)
  • 7/22/2025Chimigen Raises ~CNY 170M to Advance Cancer and HepB Vaccines
  • 7/22/2025Innovent Secures IND for Oral GLP‑1 Agonist IBI3032 as Mazdutide Hits...
  • 7/22/2025Huadong Subsidiary Reports Strong Phase III Results for Roflumilast Cr...
  • 7/22/2025Lannacheng Secures Over CNY 300M in Series C+ to Advance Radiopharma P...
  • 7/22/2025Suzhou Ribo Raises Over CNY 200M to Advance siRNA Therapeutics
  • 7/22/2025Leads Biolabs' Hong Kong IPO Draws HK$220B in Overwhelming Demand
  • 7/22/2025AusperBio Cleared to Begin Phase III Trial of AHB-137 for Chronic HepB...
  • Page:1/779 Total number of articles:23361: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group